Found "Vaccines": 74 results
Beyond coverage decisions – Using HTA to link technology supply and population health demand
Policymakers across the world are regularly required to make crucial decisions about resource allocation and prioritize interventions – medicine A or medicine B, subsidize heart surgery or expand the immunization program.
This process is required to be transparent, accountable a
Pneumococcal conjugate vaccines now introduced in Bhutan
In 2016 Bhutan graduated from Gavi support as its socioeconomic status change from lower-income to lower-middle income country, hence introducing new vaccines to its routine vaccination programme can pose a long-term financial burden to the government. However, since pneumococcal infections is a maj
Exploring Vaccine Implementation for Gavi Graduating Countries: Bhutan’s Rotavirus Vaccine Economic Evaluation
Post-graduation from Gavi support in 2016, the Bhutan Health Trust Fund took up investment for vaccine provision in the country according to its mandate. The Fund also aims to “eliminate financing uncertainties for priority core components of the Primary Health Care Services out of the income genera
Advancing Universal Health Coverage Through Health Technology Assessment (HTA) – A Perspective from Kerala
The 2019 National University of Singapore (NUS) Initiative to Improve Health in Asia Leadership Development Programme (NIHA LDP) was held at NUS, Singapore from the 24th – 29th June. The event aimed to equip policy-makers with an understanding of health technology assessment (HTA) for health care p
China using Health Technology Assessment to guide healthcare policy making is the right direction!
Partners from the International Decision Support Initiative (iDSI) join the 2nd China Health Technology Assessment Conference organised by the China National Health Development Research Center (CNHDRC) on 26-27 October 2019 in Beijing, China. The event brings together China’s high-level representati
Vaccinology for Clinical and Public Health Practice: Policy Symposium and Workshop: From participant’s perspective
This blog has been jointly written by Dr. Phetsavanh Chanthavilay from the Institute of Research and Education Development, University of Health Sciences, Lao PDR, and Mr. Nantasit Luangasanatip from the Mahidol-Oxford Tropical Medicine Research Unit, Thailand. Their participation in this e
EQUITY AS A CORNERSTONE OF A STRONG HEALTH SYSTEM: LESSONS FROM THE COVID-19 PANDEMIC
As we approach the end of an unprecedented year, the approval of select COVID-19 vaccines by stringent regulatory authorities and programmatic roll-out has been cause for optimism. However, it is imperative to assure equitable access to those in need in all regions of the world as a core component o
Are COVID-19 vaccines with 90% efficacy always better than ones with 70% efficacy?
In the late year of 2020, the COVID-19 vaccines in the news which claim itself for possessing 90% efficacy seems to be the light at the end of the tunnel for all population in the world. All eyes are being kept on the upcoming promising vaccines while ones with lower efficacy are seen scept
How Should Ethiopia’s Government Respond to COVID – 19 in a Cost Effective Way?
To support government decision-making to address the COVID-19 outbreak, the National Data Management Center (NDMC) of the Ethiopia Public Health Institute (EPHI) conducted a systematic review of the economic evaluations of public health measures for the prevention and control of pandemics. The study
How can chatbots address vaccine hesitancy? A study from Asia explores
Vaccines have been a game-changer in the fight against COVID-19. Yet, vaccine hesitancy has impeded its uptake, impacting public health efforts. At the outset of the pandemic, people had doubts about this unfamiliar virus and subsequently, the vaccine: misinformation, rumours, and doubts about COVID
10 / Page